Over at Law & Liberty, Dr. Dalrymple covers—and criticizes—the recent settlement by a French advertising company responsible for the promotion of oxycontin, which is at the heart of the ‘opioid epidemic’ in the United States.

Still, to extract money by threatening the possibility of something even worse, and then spending it on an activity of doubtful value, or an activity that could be easily funded some other way, seems to me scarcely dignified, or even compatible with the rule of law.